IGCS shares knowledge to establish high standards and raise public awareness for detection and treatment of women’s cancer. Learn More 

EducateIGCS shares knowledge...

Alliances with organizations whose goals align with those of the IGCS strengthen our message and broaden the reach of our mission. Learn More 

CollaborateAlliances with organizations...

To enhance the care of women with gynecologic cancer worldwide through education, training, and public awareness. Learn More 

Our MissionTo enhance the care of women...

IGCS membership includes experts in women’s cancer care from around the world. Learn More 

LeadIGCS membership includes...

Our members are valuable resources that facilitate professional connections on a global scale to share knowledge to improve the lives of women with cancer. Learn More 

UniteOur members are valuable...

IGCS members advocate on behalf of patients to empower and protect their interests and strive to provide patients access to available resources. Learn More 

AdvocateIGCS members advocate on...

Meet our members working hard around the globe in the fight against gynecologic cancers. Learn More 

Member SpotlightMeet our members...

Featured Announcements

Dr. Michael Quinn receives Recognition Award
Dec 08, 2016

Prof. Michael Quinn receives the Jeannie Ferris Cancer Australia Recognition Award for Health Profes...

read more

Photos from 2016 Biennial Meeting in Lisbon
Dec 06, 2016

Photos from the 2016 IGCS Biennial Meeting in Lisbon are now available on the IGCS Facebook page. &n...

read more

2016: The Year of Compassion
Nov 27, 2016

Dear Reader; As Editor in Chief of The International Journal of Gynecological Cancer (IJGC), I was a...

read more

Featured IJGC Article Blog: November 2016
Nov 21, 2016

Featured IJGC Article Blog: Challenges in the management of advanced vulvar cancer By Jessica McAlpi...

read more

2017 Membership Renewal
Nov 18, 2016

Please submit payment for 2017 membership dues by Dec. 31, 2016   Attention current IGCS member...

read more

Thanks to the Kenes Group!
Nov 07, 2016

Thanks to the Kenes Group for making the 2016 Biennial Meeting a success! The 2016 Biennial Meeting ...

read more


We strive for global representation, reflecting the diverse cultural, economic and geographic impact of gynecologic cancer. IGCS is the only organization with diverse membership and leadership.

Our Patients

Are women affected by cancers of the reproductive system..

read more

Gynecologic Cancers

Endometrial (Uterine)

read more

New Cancer Cases

According to comprehensive 2012 global cancer statistics from the International Agency for Research on Cancer, gynecologic cancer accounted for 16.3% of 6.6 million estimated new cancer cases in women.

read more


  • Gynecologic Oncologist
  • Surgical Oncologist
  • Medical Oncologist
  • Pathologist
  • Radiation Oncologist
  • Allied Health
  • Residents
  • Fellows


North America


Central America & Carribean


South America






Middle East





member spotlight

Mauricio Magalhães CostaHead of Gynecologic Oncology, Universidade Federal do Rio de Janeiro / Americas Medical City

I decided to pursue a career in gynecologic oncology because gynecological cancer is a public health problem in low- and middle-income countries, especially in Latin America. Developing programs of prevention and early detection is a very important mission and all gynecologists should be prepared to promote it in their communities. From the beginning of my career I felt the importance of this work and started to participate in public campaigns in the Amazon region, slums in Rio de Janeiro and finally as a Professor in the University.

I trained in Radiumhemmet, Sweden with Prof. Nina Einhorn from 1983-1984 and I have served as Head of the Gynecologic Oncology Division at the University Hospital in Rio since 1987. I have been active for 30 years in the fight against women cancer, through academic participation, editorials, social media, event organization, member of boards of directors, specialized committee and executive positions in medical societies and NGOs, locally, nationally in Latin American globally. I intend to use these tools to spread knowledge and improve health care in gynecology oncology.

Nadeem R. Abu-RustumChief Gynecology Service, Memorial Sloan Kettering Cancer Center

I decided to pursue a career in gynecologic oncology to cure gynecologic cancers with the most precise and novel treatment strategies, while minimizing side effects and promoting the highest quality of life to our patients.  As Chief of the Gynecologic Oncology Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center, where I also serve as Vice-Chair for Technology Development and heavily involved on a daily basis with clinical and research activities related to gynecologic oncology. Additionally, as the Avon Chair in Gynecologic Oncology and Professor of Obstetrics and Gynecology at Weill Cornell Medical College I work very closely with all members of our disease management team to promote the highest quality of clinical care and research. My clinical research focuses on surgical therapy for gynecologic cancers and innovative surgical approaches, including sentinel node mapping, improved localization of tumors, fertility-sparing surgery, and laparoscopy. In my current role at Memorial Sloan Kettering Cancer Center, I am actively involved in the development and improvement of minimally invasive techniques and oversee surgical research programs. I served as a member of the Gynecologic Oncology Group Cervix Committee and the American College of Surgeons Committee on Emerging Surgical Technology and Education. I have authored or co-authored more than 200 publications and is co-author to numerous book chapters and three textbooks in gynecologic oncology. As vice-chair of the NCCN Cervical/Uterine/Vulva Cancers Panel I am actively involved in the development on national guidelines in gynecologic oncology.

Andreas ObermairDirector of Research, Queensland Centre for Gynaecological Cancer; Professor at the University of Queensland

IGCS Member since 1996 

It strikes me that cancer causes enormous human damage. On the other hand, I am acutely aware that not only cancer but also cancer treatment causes enormous damage and harm to patients. The cost of survival sometimes is very high and this is especially pronounced in surgical oncology, such as in our specialty. My mission is to make the world of surgery more gentle and kinder while not compromising effectiveness. Our speciality is ideally positioned to help women who often don’t demand help for themselves. 

I work as a clinician, gynaecological cancer surgeon in the Australia public hospital system and I also established an active private practice where patients specifically ask to see me. I also run a research unit and we have always focused on clinical trials because trials generate research knowledge that can be implemented into clinical practice and translated into real clinical outcomes straight away. I am the driver of clinical trials that established evidence for treatments that reduce some of the suffering from gynaecological cancer.  The Cherish Women’s Cancer Foundation, which I co-founded, raises some of the funds that are required to run these clinical trials and the research work that is required to prepare for clinical trials. I also established SurgicalPerformance.com. As gynaecological surgeons we are most of the times convinced that we do an awesome job most of the times. When complications develop we feel down and believe we have done an awful job. SurgicalPerformance allows us to assess our surgical performance rationally and in confidence.

Gini FlemingProfessor of Medicine, The University of Chicago Medical Center

IGCS Member since 1997

I became a medical oncologist because I found tumor biology and the development of new treatments for cancer fascinating.  When I was hired, the gynecologic oncologists needed a medical oncology liaison to be able to join the Gynecologic Oncology Group (GOG), and I loved working with patients with these tumor types. I also see breast cancer patients. I see patients with breast cancer and gyn malignancies in clinic and work closely with our developmental therapeutics group; much of my practice is devoted to developing and running clinical trials, from early to late stage. I chair the elderly working group (devoted to improving therapy for older patients) in the NRG. I direct the protocol office for the Alliance for Clinical Trials in Oncology.


in the fight against women’s cancer worldwide

Apply for a Membership